These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18830571)

  • 1. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.
    Balakumar P; Chakkarwar VA; Singh M
    Mol Cell Biochem; 2009 Jan; 320(1-2):149-62. PubMed ID: 18830571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.
    Chakkarwar VA
    Vascul Pharmacol; 2011; 55(5-6):163-8. PubMed ID: 21864717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat.
    Balakumar P; Sharma R; Singh M
    Pharmacol Res; 2008; 58(5-6):356-63. PubMed ID: 18951979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Verma S; Reddy K; Balakumar P
    Biol Trace Elem Res; 2010 Oct; 137(1):96-109. PubMed ID: 19943121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
    Kaur J; Reddy K; Balakumar P
    Cardiovasc Toxicol; 2010 Sep; 10(3):227-38. PubMed ID: 20694523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
    Bishnoi HK; Mahadevan N; Balakumar P
    Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
    Arora MK; Reddy K; Balakumar P
    Eur J Pharmacol; 2010 Jun; 636(1-3):137-44. PubMed ID: 20347778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.
    Balakumar P; Varatharajan R; Nyo YH; Renushia R; Raaginey D; Oh AN; Akhtar SS; Rupeshkumar M; Sundram K; Dhanaraj SA
    Pharmacol Res; 2014 Dec; 90():36-47. PubMed ID: 25263930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy.
    Kadian S; Mahadevan N; Balakumar P
    Eur J Pharmacol; 2013 Jan; 698(1-3):388-96. PubMed ID: 23085026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
    Bhardwaj P; Khanna D; Balakumar P
    Cardiovasc Toxicol; 2014 Mar; 14(1):41-51. PubMed ID: 24048981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of Diabetes-Induced Diabetic Nephropathy by Aloe vera: Implication of Oxidative Stress and Hyperlipidemia.
    Arora MK; Sarup Y; Tomar R; Singh M; Kumar P
    J Diet Suppl; 2019; 16(2):227-244. PubMed ID: 29621403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Kaur T; Goel RK; Balakumar P
    Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
    Shah DI; Singh M
    Mol Cell Biochem; 2006 Feb; 283(1-2):191-9. PubMed ID: 16444602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy.
    Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A
    J Cell Biochem; 2018 Sep; 119(9):7458-7469. PubMed ID: 29761900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
    Nirwane A; Pawar V; Majumdar A
    J Complement Integr Med; 2015 Jun; 12(2):143-51. PubMed ID: 25870973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.
    Kathuria S; Mahadevan N; Balakumar P
    Mol Cell Biochem; 2013 Feb; 374(1-2):61-72. PubMed ID: 23149826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARγ-eNOS-NO signals.
    Taneja G; Mahadevan N; Balakumar P
    Cardiovasc Toxicol; 2013 Jun; 13(2):110-22. PubMed ID: 23208382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorative potential of angiotensin1-7/Mas receptor axis in streptozotocin-induced diabetic nephropathy in rats.
    Singh T; Singh K; Sharma PL
    Methods Find Exp Clin Pharmacol; 2010; 32(1):19-25. PubMed ID: 20383342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats.
    Shah DI; Singh M
    Mol Cell Biochem; 2007 Jan; 295(1-2):65-74. PubMed ID: 16841179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
    Jindal S; Singh M; Balakumar P
    Int J Cardiol; 2008 Aug; 128(3):383-91. PubMed ID: 17658639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.